Clinical Trials Browser

Recruiting × ruxolitinib × Genitourinary × Clear all

NCT07219576 2026-01-13

PRISM

Phase 1/2 Recruiting

GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell

NCT06616155 2025-12-08

Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Phase 1/2 Recruiting

Prostatic Neoplasms